Charles River Laboratories
619 hedge funds and large institutions have $10.1B invested in Charles River Laboratories in 2023 Q3 according to their latest regulatory filings, with 80 funds opening new positions, 229 increasing their positions, 218 reducing their positions, and 61 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
6% less capital invested
Capital invested by funds: $10.7B → $10.1B (-$596M)
35% less call options, than puts
Call options by funds: $40.7M | Put options by funds: $62.7M
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
619
Holding in Top 10
3
Calls
$40.7M
Puts
$62.7M
Top Buyers
| 1 | +$173M | |
| 2 | +$78.4M | |
| 3 | +$43.3M | |
| 4 |
KBC Group
Brussels,
Belgium
|
+$41.8M |
| 5 |
AC
Armistice Capital
New York
|
+$30.6M |
Top Sellers
| 1 | -$160M | |
| 2 | -$63.2M | |
| 3 | -$59.8M | |
| 4 |
Fidelity International
Hamilton,
Bermuda
|
-$40.8M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$37.9M |